Pityriasis versicolor: A systematic review of interventions

Archives of Dermatology

Volumn 146, Issue 10, 2010, Pages 1132-1140

  Hu, Stephanie W ^a   Bigby, Michael ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIFONAZOLE; CICLOPIROX; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; FLUTRIMAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; PLACEBO; POTASSIUM HYDROXIDE; PYRITHIONE ZINC; SELENIUM SULFIDE; WHITFIELD OINTMENT;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BURNING SENSATION; CLINICAL TRIAL; DERMATITIS; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; DYSPEPSIA; DYSPNEA; ERYTHEMA; FATIGUE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LIVER FUNCTION TEST; MICROSCOPY; NAUSEA; PRIORITY JOURNAL; PRURITUS; RASH; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; SKIN IRRITATION; SMEAR; SWEATING; SYMPTOM; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TINEA VERSICOLOR; TREATMENT DURATION; TREATMENT OUTCOME; URINE COLOR; VOMITING; CONTROLLED CLINICAL TRIAL (TOPIC); META ANALYSIS;

CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; TINEA VERSICOLOR;

EID: 77958195224     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.259     Document Type: Review

References (107)

1. Faergemann J. Pityriasis versicolor. Semin Dermatol. 1993;12(4):276-279.
2. Szepietowski JC, Baran E, Wild E. Tinea versicolor: a perspective study. Korean J Med Mycol. 2000;5:108-112.
3. Crespo Erchiga V, Delgado Florencio V. Malassezia species in skin diseases. Curr Opin Infect Dis. 2002;15(2):133-142.
4. Gupta AK, Bluhm R, Summerbell R. Pityriasis versicolor. J Eur Acad Dermatol Venereol. 2002;16(1):19-33.
5. Faergemann J. The role of Malassezia yeasts in skin diseases. Mikol Lek. 2004;11:129-133.
6. Schwartz RA. Superficial fungal infections. Lancet. 2004;364(9440):1173- 1182.
7. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323(7303):42-46.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
9. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. October 13, 2006;6:50.
10. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM. MIX: comprehensive free software for meta-analysis of causal research data: version 1.7. 2008. http://mix-for-meta-analysis.info. Accessed June 30, 2008.
11. Rekacewicz I, Guillaume JC, Benkhraba F, et al. A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor [in French]. Ann Dermatol Venereol. 1990;117(10):709-711.
12. Savin RC, Horwitz SN. Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol. 1986;15(3):500-503.
13. Lange DS, Richards HM, Guarnieri J, et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 1998;39(6):944-950.
14. Sun XY, Che C, Miu ZQ. The clinical observation of 2% ketoconazole lotion in treating tinea versicolor. Chinese J Dermatovenereol. 2000;14(4):288.
15. Sun ZP. 35 cases curative effect observation of 2% ketoconazole lotion in treating tinea versicolor in children. Chinese J Dermatovenereol. 2000;14(6):433-434.
16. Lu JQ. A randomised controlled trial of 2% ketoconazole. J Clin Dermatol. 2000;29(4):225-226.
17. Wang A, Li R, Wang D, et al. A randomised, double-blind, placebo-controlled clinical trial of 2% ketoconazole shampoo in the treatment of dandruff, seborrheic dermatitis and tinea versicolor. Chinese J Clin Pharmacol. 1995;11(4):200-205.
18. Mei CS. The clinical observation of 2% ketoconazole lotion in treating tinea versicolor. Chinese J Dermatovenereol. 2001;15(1):69.
19. Raad AJ, Bendck BMA. Topical treatment of pytiriasis versicolor [in Spanish]. Unimetro. 1988;4(7):50-53.
20. Ramali L, Werdani S, Sadeli R. A comparative study of the efficacy of 2% ketoconazole shampoo and 25% sodium thiosulfate solution for patients with pityriasis versicolor [abstract]. Ann Dermatol Venerol. 2002;129(suppl):1S670- 1S671.
21. Zulunga de Cadena A. Ketoconazole cream and shampoo efficacy, and selenium sulfide shampoo in the treatment of pytiriasis versicolor [in Spanish]. Revista CES Med. 1989;3(2):69-76.
22. Rigopoulos D, Gregoriou S, Kontochristopoulos G, Ifantides A, Katsambas A. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor: a randomized double-blind comparative trial. Mycoses. 2007;50(3):193-195. (Pubitemid 46683977)
23. Liu C, Qu R, Fang J. The effect of 1% bifonazole solution for treating tinea versicolor. Chinese J Dermatovenereol. 2001;15(4):252-253.
24. Segal R, Kricheli D, Zukrov B, David M. Treatment of pityriasis versicolor with bifonazole shampoo: a randomized double-blind study. J Dermatolog Treat. 1999;10(3):185-188. (Pubitemid 29438078)
25. Mora RG, Greer DL. Comparative efficacy and tolerance of 1% bifonazole cream and bifonazole cream vehicle in patients with tinea versicolor. Dermatologica. 1984;169(1)(suppl 1):87-92.
26. Galimberti RL, Bonino M, Flores V, et al. Ultra-short topical treatment of pityriasis versicolor with 2.5% bifonazole cream. Clin Exp Dermatol. 1993;18(1):25-29. (Pubitemid 23043841)
27. del Palacio-Hernanz A, Lopez-Gomez S, Gonzalez-Lastra F. Tratameinto corto con ciclopirox olamina1%ciclochem en pitiriasis versicolor. Actas Dermosifiliogr. 1988;79(4):365-369.
28. Mejias de Alejo MA, Drikha de Chami H, Araujo MH. Alternatives in the treatment of pityriasis versicolor with bofonazole 1 per cent solution [in Spanish]. Dermatol Venez. 1991;29(2):55-58.
29. Smith EB, Tschen E. Treatment of interdigital tinea pedis and tinea (pityriasis) versicolor with bifonazole 1% solution applied once daily. Adv Ther. 1986;3(5):250-256. (Pubitemid 17002846)
30. Goffe B. Response of tinea corporis/cruris and tinea (pityriasis) versicolor to once daily topical treatment with bifonazole cream - a safety and efficacy study. Adv Ther. 1986;3(5):289-293. (Pubitemid 17002851)
31. Hernández-Pérez E. A comparison between one and two weeks' treatment with bifonazole in pityriasis versicolor. J Am Acad Dermatol. 1986;14(4):561-564.
32. del Palacio-Hernanz A, López Gómez S, Iglesias Diez L. Short course bifonazole therapy in pityriasis versicolor. Clin Exp Dermatol. 1987;12(4):270-272.
33. Aste N, Pau M, Cordaro CI, Biggio P. Double-blind study with fenticonazole or bifonazole lotions in pityriasis versicolor. Int J Clin Pharmacol Res. 1988;8(4):271-273.
34. Aste N, Pau M, Pinna AL, Colombo MD, Biggio P. Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses. 1991;34(7-8):353-357.
35. Alomar A, Videla S, Delgadillo J, Gich I, Izquierdo I, Forn J; Catalan Flutrimazole Study Group. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole1% cream: efficacy of flutrimazole1%dermal cream in dermatomycoses. Dermatology. 1995;190(4):295-300.
36. Chu AC. Comparative clinical trial of bifonazole solution versus selenium sulphide shampoo in the treatment of pityriasis versicolor. Dermatologica. 1984;169(1)(suppl 1):81-86.
37. Clerico R, Ribuffo A. Efficacy and tolerance of fenticonazole versus miconazole cream. Int J Clin Pharmacol Res. 1987;7(1):77-81.
38. Fredriksson T. Treatment of dermatomycoses with topical tioconazole and miconazole. Dermatologica. 1983;166(1)(suppl 1):14-19.
39. Tanenbaum L, Anderson C, Rosenberg M, Akers W. 1% sulconazole cream versus 2% miconazole cream in the treatment of tinea versicolor: a double-blind, multicenter study. Arch Dermatol. 1984;120(2):216-219.
40. Unlu S, Ozturkcan S, Marufihah M. The comparison of the effects of 1% terbinafine and izoconasole creams in treatment of pityriasis versicolor. J Eur Acad Dermatol Venereol. 1995;5(1):S172.
41. Duweb GA, Elabbar ZM, Benghuzzi NK. Pityriasis versicolor: two-weeks topical 1% terbinafine cream versus 1% ketoconazole cream. J Eur Acad Dermatol Venereol. 1999;12(2):S299.
42. Faergemann J, Hersle K, Nordin P. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. Dermatology. 1997;194(1)(suppl 1):19-21.
43. Savin R, Eisen D, Fradin MS, Lebwohl M. Tinea versicolor treated with terbinafine 1% solution. Int J Dermatol. 1999;38(11):863-865.
44. Vermeer BJ, Staats CCG. The efficacy of a topical application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo-controlled study. Dermatology. 1997;194(1)(suppl 1):22-24.
45. El-Kharraz SO, Dubweb GA, Elzorghany AH, et al. Topical terbinafine: one week versus two weeks treatment in pityriasis versicolor. J Eur Acad Dermatol Venereology. 2002;16(1):115-341.
46. Williams T, Hettler O, Hall M. Summary of efficacy and tolerability of two new topical formulations of terbinafine (1% solution & 1%emulsion gel) in the treatment of pityriasis versicolor. J Eur Acad Dermatol Venereol. 1998;11(2):S237.
47. Haroon TS, Jahangir M, Hussain I, et al. A randomized, double-blind, placebo-controlled, multicentre, parallel-group study of the efficacy and safety of terbinafine 1% topical solution, applied twice daily for one week in patients with pityriasis versicolor. Specialist Q. 1999;16(1):51-55.
48. Budimulja U, Paul C. One-week terbinafine 1% solution in pityriasis versicolor: twice-daily application is more effective than once-daily. J Dermatolog Treat. 2002;13(1):39-40.
49. Hira SK, Din SN, Patel JS. Econazole 1% in the treatment of pityriasis versicolor in Zambia. J Am Acad Dermatol. 1985;12(3):580-581.
50. Vicik GJ, Mendiones M, Quinones CA, Thorne EG. A new treatment for tinea versicolor using econazole nitrate 1.0 percent cream once a day. Cutis. 1984;33(6):570-571.
51. Katsambas A, Rigopoulos D, Antoniou C, Zachari A, Fragouli E, Stratigos J. Econazole 1% shampoo versus selenium in the treatment of tinea versicolor: a single-blind randomized clinical study. Int J Dermatol. 1996;35(9):667-668.
52. Quiñones CA. Tinea versicolor: new topical treatments. Cutis. 1980;25(4):386-388.
53. Zaias N, Battistini F. Superficial mycoses: treatment with a new, broad-spectrum antifungal agent: 1% clotrimazole solution. Arch Dermatol. 1977;113(3):307-308. (Pubitemid 8054409)
54. Spiekermann PH, Young MD. Clinical evaluation of clotrimazole: a broadspectrum antifungal agent. Arch Dermatol. 1976;112(3):350-352.
55. Tham SN. Treatment of pityriasis versicolor: comparison of sulconazole nitrate 1% solution and clotrimazole 1% solution. Australas J Dermatol. 1987;28(3):123-125.
56. Clayton YM, Connor BL. Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis. Br J Dermatol. 1973;89(3):297-303.
57. Clayton R, Du Vivier A, Savage M. Double-blind trial of 1% clotrimazole cream and Whitfield ointment in the treatment of pityriasis versicolor. Arch Dermatol. 1977;113(6):849-850. (Pubitemid 8203693)
58. Hira SK, Abraham MS, Mwinga A, Kamanga J, Schmidt C. Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia. Mykosen. 1986;29(8):378-381.
59. Montoya F, Vélez H. Therapeutic evaluation of naftifine in patients with dermatophytosis and tinea versicolor [in Spanish]. Acta Med Colomb. 1985;10(2):79-94.
60. Gonzalez-Ochoa A, Sarmiento-Cristobal J, Ortega-Llamas O. Investigacion clinica sobre el hoe 296 en dermatofitosis de la piel lampiña y en pitiriasis versicolor. Rev Panam Salud Publica. 1974;34(4):175-181.
61. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%. Clin Ther. 1985;7(5):574-583. (Pubitemid 15238795)
62. Rigopoulos D, Katsambas A, Antoniou C, Polydorou D, Vlachou M, Stratigos J. Tinea versicolor treated with fluconazole shampoo. Int J Dermatol. 1992;31(9):664-665.
63. Nasarre J, Umbert P, Herrero E, et al. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of pityriasis versicolor. Arzneimittelforschung. 1992;42(5A):764-767.
64. Sánchez JL, Torres VM. Double-blind efficacy study of selenium sulfide in tinea versicolor. J Am Acad Dermatol. 1984;11(2, pt 1):235-238.
65. Hull CA, Johnson SM. A double-blind comparative study of sodium sulfacetamide lotion 10% versus selenium sulfide lotion 2.5% in the treatment of pityriasis (tinea) versicolor. Cutis. 2004;73(6):425-429.
66. Fredriksson T, Faergemann J. Double-blind comparison of a zinc pyrithione shampoo and its shampoo base in the treatment of tinea versicolor. Cutis. 1983;31(4):436-437.
67. Bamford JT. Treatment of tinea versicolor with sulfur-salicylic shampoo. J Am Acad Dermatol. 1983;8(2):211-213.
68. Kashin P, Phyfferoen MC, Gibbs DL. A comparative study of once versus twice daily treatment of superficial dermatophyte and yeast infections with tioconazole (1%) cream. J Int Med Res. 1985;13(2):88-95.
69. Montes LF, Oakes RA, Pert P, Glick L, Nimni ME. Topical griseofulvin in tinea versicolor: a double-blind study. J Am Acad Dermatol. 1991;25(4):726-728.
70. Prestia AE. Topical benzoyl peroxide for the treatment of tinea versicolor. J Am Acad Dermatol. 1983;9(2):277-278.
71. Estrada RA. Itraconazole in pityriasis versicolor. Rev Infect Dis. 1987;9(1)(suppl 1):S128-S130.
72. Morales-Doria M. Pityriasis versicolor: efficacy of two five-day regimens of itraconazole. Rev Infect Dis. 1987;9(1)(suppl 1):S131-S133.
73. Galimberti RL, Villalba I, Galarza S, Raimondi A, Flores V. Itraconazole in pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment. Rev Infect Dis. 1987;9(1)(suppl 1):S134-S138.
74. Cucé LC, Belda Júnior W, Ribeiro EB. Itraconazole in the treatment of pityriasis versicolor: comparison between 5 and 7 days of treatment [in Portuguese]. Rev Inst Med Trop Sao Paulo. 1990;32(3):181-184.
75. del Palacio-Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, van Cutsem J, Cauwenbergh G. Itraconazole therapy in pityriasis versicolor. Br J Dermatol. 1986;115(2):217-225.
76. Hickman JG. A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. J AmAcad Dermatol. 1996;34(5, pt 1):785-787.
77. Köse O, Bülent Taśtan H, Riza Gür A, Kurumlu Z. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor. J Dermatolog Treat. 2002;13(2):77-79.
78. Roseeuw D, Willemsen M, Kint RT, Peremans W, Mertens RL, Van Cutsem J. Itraconazole in the treatment of superficial mycoses - a double-blind study vs placebo. Clin Exp Dermatol. 1990;15(2):101-104.
79. Elorfi A, Bugrien A. Itraconazole for pityriasis versicolor. Ann Dermatol Venereol. 2002;129(suppl):S661.
80. Faergemann J. Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study. Mycoses. 1988;31(7):377-379.
81. Bhogal CS, Singal A, Baruah MC. Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. J Dermatol. 2001;28(10):535-539.
82. Fernandez-Nava HD, Laya-Cuadra B, Tianco EAV. Comparison of single dose 400 mg versus 10-day 200 mg daily dose ketoconazole in the treatment of tinea versicolor. Int J Dermatol. 1997;36(1):64-66.
83. Zaias N. Pityriasis versicolor with ketoconazole. J Am Acad Dermatol. 1989;20(4):703-705.
84. Savin RC. Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up. J Am Acad Dermatol. 1984;10(5, pt 1):824-830.
85. Urcuyo FG, Zaias N. The successful treatment of pityriasis versicolor by systemic ketoconazole. J Am Acad Dermatol. 1982;6(1):24-25.
86. Hay RJ, Midgeley G. Short course ketoconazole therapy in pityriasis versicolor. Clin Exp Dermatol. 1984;9(6):571-573.
87. Sampaio SA, Freitas TH, Sabogal MF. Tratamento da pitiriase versicolor pelo ketoconazole/Treatment of pityriasis versicolor with ketoconazole. An Bras Dermatol. 1983;58(6):245-248.
88. Sampaio SAP, Zeminiam PS, Salebian A. Ketoconazole in pityriasis versicolor: a comparative study between 2 schemes of treatment, 10 and 20 days [in Portuguese]. An Bras Dermatol. 1985;60(1):41-44.
89. Montero-Gei F, Robles ME, Suchil P. Fluconazole vs itraconazole in the treatment of tinea versicolor. Int J Dermatol. 1999;38(8):601-603.
90. Partap R, Kaur I, Chakrabarti A, Kumar B. Single-dose fluconazole versus itraconazole in pityriasis versicolor. Dermatology. 2004;208(1):55-59.
91. D'Oliveira Júnior A, Machado PR, Carvalho EM. Evaluating the efficacy of allopurinol for the treatment of cutaneous leishmaniasis. Int J Dermatol. 1997;36(12):938-946.
92. Farschian M, Yaghoobi R, Samadi K. Fluconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatolog Treat. 2002;13(2):73-76.
93. Yazdanpanah MJ, Azizi H, Suizi B. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. Mycoses. 2007;50(4):311-313.
94. Montero-Gei F. Fluconazole efficacy in tineas and pityriasis versicolor. J Eur Acad Dermatol Venereol. 2006;11(2):S95-S109.
95. Silva H, Gibbs D, Arguedas J. A comparison of fluconazole with ketoconazole, itraconazole, and clotrimazole in the treatment of patients with pityriasis versicolor. Curr Ther Res. 1998;59(4):203-214.
96. del Palacio-Hernanz A, Delgado Vicente S, Menéndez Ramos F, Rodríguez-Noriega Belaustegui A. Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor. Rev Infect Dis. 1987;9(1)(suppl 1):S121-S127.
97. Faergemann J, Djärv L. Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis. 1982;30(4):542-545, 550.
98. Faergemann J, Gupta AK, Al Mofadi A, Abanami A, Shareaah AA, Marynissen G. Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch Dermatol. 2002;138(1):69-73.
99. Difonzo EM. Italian multicentre study with oral itraconazole in recurrent pityriasis versicolor: preliminary report. J Eur Acad Dermatol Venereol. 1992;1:S19-S20.
100. Wang Y, Liu JC, Liu LC, et al. A comparative clinical study of the consolidation treatment of itraconazole in pityriasis versicolor. J Clin Dermatol. 2006;35(6):376-377.
101. Hernàndez-Pèrez E. A comparison between two different regimens of monthly application with bifonazole spray 1% in pityriasis versicolor. Int J Dermatol. 1990;29(6):438-440.
102. Pocock SJ, Ware JH. Translating statistical findings into plain English [published online April 15, 2009]. Lancet. 2009;373(9679):1926-1928.
103. Ashley ED, Perfect JR. Pharmacology of azoles. UpToDate Online 17.1. http://www.uptodate.com. Accessed June 30, 2008.
104. Terrell CL. Antifungal agents: part II: the azoles. Mayo Clin Proc. 1999;74(1):78-100.
105. Lyman CA, Walsh TJ. Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs. 1992;44(1):9-35.
106. García Rodríguez LA, Duque A, Castellsague J, Pérez-Gutthann S, Stricker BH. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol. 1999;48(6):847-852.
107. Bigby M, Stern RS, Bigby JA. An evaluation of method reporting and use in clinical trials in dermatology. Arch Dermatol. 1985;121(11):1394-1399.